Managing blood glucose control in the intensive care unit
Jan Gunst, Guillermo E. Umpierrez, Greet Van den Berghe
Abstract
sponsorship: JG holds a senior clinical investigator fellowship granted by Research Foundation-Flanders (1842724N) and receives research funding by KU Leuven (STG/23/032) and the European Society of Intensive Care Medicine (2022 Fundamental Research Award). GVdB receives structural research financing through KU Leuven via the Methusalem Program of the Flemish Government (METH14/06) and research funding by the European Research Council of the European Union (advanced grants AdvG-2017-785809 and 101133276 (ERC- 2023-AdG) from the Horizon Europe Program). GEU is supported by research grants from the National Institutes of Health (NATS UL 3UL1TR002378-05S2), from the Clinical and Translational Science Award program, and from the National Institutes of Health and National Center for Research Resources (NIH/NIDDK 2P30DK111024-06), and has served as a member of advisory boards for Dexcom and GlyCare. (Research Foundation-Flanders|1842724N, KU Leuven|STG/23/032, European Society of Intensive Care Medicine, KU Leuven via the Methusalem Program of the Flemish Government|METH14/06, European Research Council of the European Union from the Horizon Europe Program|AdvG-2017-785809, European Research Council of the European Union from the Horizon Europe Program|101133276, European Research Council of the European Union from the Horizon Europe Program|ERC- 2023-AdG, National Institutes of Health|NATS UL 3UL1TR002378-05S2, Clinical and Translational Science Award program, National Institutes of Health and National Center for Research Resources|NIH/NIDDK 2P30DK111024-06)